首页> 外国专利> PROTECTIVE PLASMODIUM FALCIPARUM HYBRID PROTEINS COMPRISING PARTIAL SEQUENCES OF MALARIA ANTIGENE HRPII AND SERP, THEIR PREPARATION AND USE

PROTECTIVE PLASMODIUM FALCIPARUM HYBRID PROTEINS COMPRISING PARTIAL SEQUENCES OF MALARIA ANTIGENE HRPII AND SERP, THEIR PREPARATION AND USE

机译:包含疟疾抗原HRPII和SERP部分序列的恶性疟原虫混合蛋白及其制备和用途

摘要

The invention relates to hybrid proteins consisting of partial sequences of the malaria antigens HRPII and SERP. The HRPII sequence has already proved to be protective in the monkey model (EP-A2-0 315 085), use being made in the present invention, just like in the previous attempt at protection - of a C-terminal region of 189 amino acids. SERP was identified with the aid of an antiserum against a protective protein band (EP-A1-0 283 882); the partial sequence used (amino acids (AA) 631-892 or 630-764) contains at least two T-cell epitopes (Roussilhon et al. (1990), Immunol. Letters 25, 149-154). In preferred embodiments, further regions, containing T-cell epitopes, of other P. falciparum proteins such as the merozoite surface antigen I (MSA I or else 195 kd antigen), amino acids from 100 to 300, are incorporated (Crisanti et al. (1988), Science 240, 324-326). A property common to all the hybrid components is that they represent highly conserved peptide sequences. Protection against a malaria infection is generated by inoculation with abovementioned hybrid proteins.
机译:本发明涉及由疟疾抗原HRPII和SERP的部分序列组成的杂合蛋白。已经证明HRPII序列在猴模型中是保护性的(EP-A2-0 315 085),正如在先前的保护保护的尝试中一样,本发明中使用了HRPII序列-189个氨基酸的C-末端区域。借助针对保护性蛋白带的抗血清鉴定了SERP(EP-A1-0 283 882);所使用的部分序列(氨基酸(AA)631-892或630-764)含有至少两个T细胞表位(Roussilhon等人(1990),Immunol.Letters 25,149-154)。在优选的实施方案中,掺入了其他恶性疟原虫蛋白质例如裂殖子表面抗原I(MSA I或195kd抗原)的含有T细胞表位的其他区域,其氨基酸为100至300(Crisanti等人,J.Biol.Chem.Soc。,USA,1989)。 (1988),Science 240,324-326)。所有杂种组分共有的一个特性是它们代表高度保守的肽序列。通过接种上述杂合蛋白可以预防疟疾感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号